Concepedia

Effect of intensive insulin therapy on macular biometrics, plasma VEGF and its soluble receptor in newly diagnosed diabetic patients

Cristina Hernández, Miguel Ángel Zapata, Eladio Losada, Marta Villarroel, Marta García‐Ramírez, José Garcia-Arumı́, Rafael Simó

Diabetes/Metabolism Research and Reviews · 2010 · 13 citations · 26 references

DOI

Abstract

Diabetic patients with blurred vision after starting insulin therapy present a significant transient increase in macular biometrics which is associated with a decrease in circulating sFlt-1.

References

26

Diagnosis and Classification of Diabetes Mellitus

Diabetes Care · 2010 · 14K citations · Full text

Vascular endothelial growth factor (VEGF) and its receptors

Gera Neufeld, Tzafra Cohen, Stela Gengrinovitch et al. · The FASEB Journal · 1999 · 3.5K citations

, , +14

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

R.L. Kendall, Kenneth A. Thomas · Proceedings of the National Academy of Sciences · 1993 · 1.4K citations · Full text

, , +16

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Lloyd Paul Aiello, Eric A. Pierce, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1.3K citations · Full text

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

Helmut O. Steinberg, Ginger Brechtel, Andi Johnson et al. · Journal of Clinical Investigation · 1994 · 1.2K citations · Full text

, , +22